Skip to Content
Merck
  • Cerebral ischemia-reperfusion induces GAPDH S-nitrosylation and nuclear translocation.

Cerebral ischemia-reperfusion induces GAPDH S-nitrosylation and nuclear translocation.

Biochemistry. Biokhimiia (2012-07-24)
Chong Li, Jun-Jun Feng, Yong-Ping Wu, Guang-Yi Zhang
ABSTRACT

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a glycolytic enzyme, plays an important role in glycolysis. It was reported that GAPDH undergoes S-nitrosylation, which facilitated its binding to Siah1 and resulted in nuclear translocation and cell apoptosis. The results of this study show that GAPDH S-nitrosylation, Siah1 binding, translocation to nucleus, and concomitant neuron death occur during the early stages of reperfusion in the rat four-vessel occlusion ischemic model. N-Methyl-D-aspartate receptor antagonist MK801, neuronal nitric oxide synthase inhibitor 7-nitroindazole, or monoamine oxidase-B inhibitor (R)-(-)-deprenyl hydrochloride could inhibit GAPDH S-nitrosylation and translocation and exert neuroprotective effects.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
R-(−)-Deprenyl hydrochloride, powder, ≥98% (HPLC)
Sigma-Aldrich
7-Nitroindazole, ≥98%
Selegiline hydrochloride, European Pharmacopoeia (EP) Reference Standard